PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32952998-3 2019 A novel parthenolide derivative with good bioavailability and pharmacological properties was identified through a screening cascade based on in vitro anti-leukaemic activity and calculated "drug-likeness" properties, in vitro and in vivo pharmacokinetics studies and hERG liability testing. parthenolide 8-20 ETS transcription factor ERG Homo sapiens 267-271